Insulin Pump Alarms During Adverse Events: A Qualitative Descriptive Study
Authors' conclusion
Our findings demonstrate the value of analyzing alarm signals cited in insulin pump-associated AEs and reveal multiple opportunities for providers to educate patients on how to respond to alarm signals and manage their pumps to avoid AEs, and for insulin pump manufacturers to update instructional materials and improve alarm systems to support appropriate patient response.
Study context
- Population
- Insulin pump-associated adverse events (AEs) involving the MiniMed 670G, MiniMed 630G and t:slim X2
- Participants
- 2,294 AEs
- Outcome
- Alarm signals cited in insulin pump-associated AEs
Methodological detailspre-coded data set of insulin pump-associated AEs
- Pre-coded data set of insulin pump-associated AEs
Main finding
As reported in the abstract
- AE narratives citing at least one alarm signal
- 403
- Unique alarm signals cited
- 40
- Unique alarm signals that were "alarms"
- 42.5%
- Unique alarm signals that were "alerts"
- 25.0%
- Unique alarm signals not referenced in the pump's instructional materials
- 32.5%
- Share of AEs citing ≥1 alarm accounted for by two obstruction of flow alarms (among top 10)
- 49.9%
- Top 10 most frequently cited alarm signals included two unreferenced alarms
- 2
Original publication
Insulin Pump Alarms During Adverse Events: A Qualitative Descriptive Study. J Diabetes Sci Technol. Published 31 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →